Literature DB >> 32205380

Campylobacter colitis leads to toxic megacolon and multiple organ failure.

Clair Louise Taylor Clark1, Elspeth Victoria Murray2,3.   

Abstract

A 58-year-old woman presented to the emergency department in a district general hospital with severe abdominal pain and diarrhoea, after collapsing at home. She was admitted to the intensive care unit (ICU) in septic shock, and with acute kidney injury. An initial CT scan was suggestive of colitis. She was treated for suspected gastroenteritis and her microbiology results showed Campylobacter coli as the causative organism. She failed to respond to antibiotics, and underwent serial contrast CTs which showed no progression of colitis. Colonoscopy performed on day 10 of her admission, however, revealed fulminant colitis. After a multidisciplinary meeting among gastroenterologists, general surgeons and intensivists, the patient underwent total colectomy with ileostomy. She made a slow but steady recovery in ICU, and subsequently in the ward, and was discharged to a local community hospital for further rehabilitation. © BMJ Publishing Group Limited 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  adult intensive care; gastrointestinal surgery; hepatitis and other GI infections; infection (gastroenterology)

Mesh:

Year:  2020        PMID: 32205380      PMCID: PMC7103789          DOI: 10.1136/bcr-2019-233373

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  11 in total

Review 1.  Surgery for inflammatory bowel disease.

Authors:  John M Hwang; Madhulika G Varma
Journal:  World J Gastroenterol       Date:  2008-05-07       Impact factor: 5.742

2.  Disease outcome in inflammatory bowel disease: mortality, morbidity and therapeutic management of a 796-person inception cohort in the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD).

Authors:  J Witte; S Shivananda; J E Lennard-Jones; M Beltrami; P Politi; A Bonanomi; E V Tsianos; I Mouzas; T B Schulz; E Monteiro; J Clofent; S Odes; C B Limonard; R W Stockbrügger; M G Russel
Journal:  Scand J Gastroenterol       Date:  2000-12       Impact factor: 2.423

Review 3.  The clinical importance of emerging Campylobacter species.

Authors:  Si Ming Man
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-10-25       Impact factor: 46.802

Review 4.  Campylobacter jejuni Infections: update on emerging issues and trends.

Authors:  B M Allos
Journal:  Clin Infect Dis       Date:  2001-03-28       Impact factor: 9.079

Review 5.  A new look at toxic megacolon: an update and review of incidence, etiology, pathogenesis, and management.

Authors:  S Ian Gan; P L Beck
Journal:  Am J Gastroenterol       Date:  2003-11       Impact factor: 10.864

6.  Campylobacter enteritis: clinical and epidemiologic features.

Authors:  M J Blaser; I D Berkowitz; F M LaForce; J Cravens; L B Reller; W L Wang
Journal:  Ann Intern Med       Date:  1979-08       Impact factor: 25.391

Review 7.  Role of emerging Campylobacter species in inflammatory bowel diseases.

Authors:  Nadeem O Kaakoush; Hazel M Mitchell; Si Ming Man
Journal:  Inflamm Bowel Dis       Date:  2014-11       Impact factor: 5.325

8.  Aetiology and surgical management of toxic megacolon.

Authors:  C Ausch; R D Madoff; M Gnant; H R Rosen; J Garcia-Aguilar; N Hölbling; F Herbst; V Buxhofer; B Holzer; D A Rothenberger; R Schiessel
Journal:  Colorectal Dis       Date:  2006-03       Impact factor: 3.788

9.  Campylobacter genotyping to determine the source of human infection.

Authors:  Samuel K Sheppard; John F Dallas; Norval J C Strachan; Marian MacRae; Noel D McCarthy; Daniel J Wilson; Fraser J Gormley; Daniel Falush; Iain D Ogden; Martin C J Maiden; Ken J Forbes
Journal:  Clin Infect Dis       Date:  2009-04-15       Impact factor: 9.079

10.  Campylobacter colitis: Rare cause of toxic megacolon.

Authors:  Michael Kwok; Andrew Maurice; Carl Lisec; Jason Brown
Journal:  Int J Surg Case Rep       Date:  2016-08-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.